Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioMarin Pharmaceutical
Biotech
Helus CEO out after two months—Chutes & Ladders
Helus is again looking for a new CEO. Pfizer strategy chief pivots out of C suite. Paratus lands former Juniper CEO. And more.
Will Maddox
,
Zoey Becker
Apr 24, 2026 8:30am
Midsize biotechs form coalition to fight against MFN policy
Feb 25, 2026 1:05pm
RFK Jr. continues overhaul of CDC vaccine panel—Chutes & Ladders
Jan 16, 2026 8:30am
After $4.8B Amicus buy, BioMarin drops genetic disease asset
Dec 22, 2025 11:12am
Sanofi snags BioMarin leader to serve as CMO
Aug 26, 2025 11:06am
BioMarin drops PKU drug once seen as possible Palynziq successor
Aug 5, 2025 4:48am
